RP Cure Tracker

Trials / NCT06177977

SS-HH-OCT as a Novel Diagnostic Modality for Early-Onset Retinal Dystrophies (EORDs)

Completed N/A Device

Sponsor
Duke University
Treatment
SS-HH-OCT
Gene
Not stated
Conditions
Retinal Dystrophies
Ages
0 Years to 8 Years
Enrollment
137 participants
Started
2024-03-01
Main results expected
2026-02-05
Results posted
Not yet
Record last updated
2026-09-29

What the study is testing

The goal of this observational study is to utilize a novel imaging system designed for high-resolution retinal imaging of neonates, infants and children to identify the signs of photoreceptor development and degeneration in children with early-onset inherited retinal dystrophies (EORDs). Participants will have research imaging with SS-HH-OCT at the time of clinically-indicated eye examinations or procedures. The investigators aim to establish the basis for utilization of OCT imaging in earlier diagnosis and disease monitoring in children with EORDs. This work will set data reference standards and IRD endpoints that can be used in clinical trials.

Where it runs

United States (1)

Open on ClinicalTrials.gov for contacts and eligibility